Standaert, David G. http://orcid.org/0000-0003-2921-8348
Boyd, James T.
Odin, Per
Robieson, Weining Z.
Zamudio, Jorge
Chatamra, Krai http://orcid.org/0000-0002-4326-2612
Article History
Received: 26 June 2017
Revised: 12 December 2017
Accepted: 21 December 2017
First Online: 24 January 2018
Competing interests
: D. G. S. is a member of the faculty of the University of Alabama at Birmingham and is supported by endowment and University funds. D. G. S. is an investigator in studies funded by Abbvie, Inc., the American Parkinson Disease Association, the Michael J. Fox Foundation for Parkinson Research, Alabama Department of Commerce, and NIH grants P01NS087997, P20NS087997, R25NS079188, P2CHD086851, and P30NS047466. He has a clinical practice and is compensated for these activities through the University of Alabama Health Services Foundation. In addition, since 1st January 2016 he has served as a consultant for or received honoraria from Serina Therapeutics, Abbvie, Voyager Therapeutics, the Michael J. Fox Foundation for Parkinson Research, The International Parkinson Disease and Movement Disorder Society, the National Institutes of Health, The American Institute for Biological Sciences, Rush University, Huntsville Hospital, UCSD, Voyager Therapeutics, and he has received royalties for publications from McGraw Hill, Inc. J. T. B. served as a consultant and/or scientific advisor for AbbVie Inc., Auspex, Teva, Lundbeck, Chronos Therapeutics, Neurocrine, and Medical Education Resources. He has received research support from the Michael J. Fox Foundation for Parkinson Research, NIH/NINDS, Auspex, Biotie, Cure Huntington’s Disease Initiative, Vaccinex, Teva, AbbVie Inc., NeuroDerm, and Roche. P. O. was a study investigator and has received compensations for consultancy and speaker related activities from AbbVie, Britannia, Boehringer-Ingelheim, Nordic Infucare, UCB, and Zambon. P. O. has received royalties from Uni-Med Verlag. W. Z. R. and J. Z. are employees of AbbVie and hold AbbVie stock and/or stock options. K. C. is a former employee of AbbVie and and holds AbbVie stock and/or stock options.